| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hepion Pharmaceuticals, Inc. (HEPA) has 0 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. HEPA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2020 | Jacob Gary S | Director | Buy | 12,000 | $1.66 | $19,920.00 | +20,339% | |
| Nov 25, 2020 | Cavan John T | Chief Financial Officer | Buy | 4,500 | $1.62 | $7,290.00 | +1,500% | |
| Jun 20, 2017 | Cavan John T | CFO | Buy | 20,000 | $0.65 | $13,000.00 | New | |
| Feb 18, 2016 | Sapirstein James90 | Chief Executive Officer | Buy | 10,000 | $1.00 | $10,000.00 | +333.3% | |
| Nov 30, 2015 | Sapirstein James90 | Chief Executive Officer | Buy | 500 | $2.15 | $1,075.00 | +20.0% | |
| Nov 23, 2015 | Sapirstein James90 | Chief Executive Officer | Buy | 2,500 | $1.64 | $4,100.00 | New |